Perioperative Psychiatric Aspects in Neurosurgery

  • Sahil Munjal
  • Paula C. ZimbreanEmail author


Neurosurgical treatment for conditions such as epilepsy, traumatic brain injury, or brain tumor is often accompanied by perioperative psychiatric symptoms regardless of preexisting psychiatric conditions. These symptoms may be related to the underlying neurosurgical condition, the neurosurgical intervention itself (e.g., resection), or the medications used in the perioperative setting (e.g., anesthesia or corticosteroids). Comorbid neurological conditions may further complicate the management of the psychiatric presentations in this setting due to increased sensitivity to psychotropic medications or to the psychoactive effects of other agents. This chapter reviews the literature relevant to the perioperative psychiatric assessment and management in patients undergoing the most common neurosurgical procedures.


Neurosurgery Neuropsychiatry Brain tumor Traumatic brain injury Epilepsy surgery 


  1. 1.
    Dewan MC, Rattani A, Fieggen G, Arraez MA, Servadei F, Boop FA, et al. Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. Executive summary of the global neurosurgery initiative at the program in global surgery and social change. J Neurosurg. 2018:1–10.Google Scholar
  2. 2.
    Faria MA. Neolithic trepanation decoded- a unifying hypothesis: has the mystery as to why primitive surgeons performed cranial surgery been solved? Surg Neurol Int. 2015;6:72.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Preul M. History of brain tumor surgery. Neurosurg Focus. 2005;18(4):1.CrossRefGoogle Scholar
  4. 4.
    Menon DK, Schwab K, Wright DW, Maas AI. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91(11):1637–40.PubMedCrossRefGoogle Scholar
  5. 5.
    Ganau M, Lavinio A, Prisco L. Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options. Minerva Anestesiol. 2018;84(5):632–40.PubMedGoogle Scholar
  6. 6.
    Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018:1–18.Google Scholar
  7. 7.
    Bratton SL, Chestnut RM, Ghajar J, Hammond FFM, Harris OA, Hartl R, et al. VII. Intracranial pressure monitoring technology. J Neurotrauma. 2007;24(supplement 1):S-45–54.CrossRefGoogle Scholar
  8. 8.
    Feinberg M, Mai JC, Ecklund J. Neurosurgical management in traumatic brain injury. Semin Neurol. 2015;35(1):50–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury, 4th edition. Neurosurgery. 2017;80(1):6–15.PubMedGoogle Scholar
  10. 10.
    Bauer D, Tung ML, Tsao JW. Mechanisms of traumatic brain injury. Semin Neurol. 2015;35(1):e14–22.PubMedCrossRefGoogle Scholar
  11. 11.
    McIntosh AS, Patton DA, Frechede B, Pierre PA, Ferry E, Barthels T. The biomechanics of concussion in unhelmeted football players in Australia: a case-control study. BMJ Open. 2014;4(5):e005078.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    McAllister TW. Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci. 2011;13(3):287–300.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet (London, England). 1974;2(7872):81–4.CrossRefGoogle Scholar
  14. 14.
    McNett M. A review of the predictive ability of Glasgow coma scale scores in head-injured patients. J Neurosci Nurs. 2007;39(2):68–75.PubMedCrossRefGoogle Scholar
  15. 15.
    Marshall LF, Marshall SB, Klauber MR, Van Berkum CM, Eisenberg H, Jane JA, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9(Suppl 1):S287–92.PubMedGoogle Scholar
  16. 16.
    Raj R, Siironen J, Skrifvars MB, Hernesniemi J, Kivisaari R. Predicting outcome in traumatic brain injury: development of a novel computerized tomography classification system (Helsinki computerized tomography score). Neurosurgery. 2014;75(6):632–46. discussion 46-7.PubMedCrossRefGoogle Scholar
  17. 17.
    Raj R, Mikkonen ED, Siironen J, Hernesniemi J, Lappalainen J, Skrifvars MB. Alcohol and mortality after moderate to severe traumatic brain injury: a meta-analysis of observational studies. J Neurosurg. 2016;124(6):1684–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Malec JF, Brown AW, Leibson CL, Flaada JT, Mandrekar JN, Diehl NN, et al. The mayo classification system for traumatic brain injury severity. J Neurotrauma. 2007;24(9):1417–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, et al. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016;174(1–3):77–81.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Castano Monsalve B, Bernabeu Guitart M, Lopez R, Bulbena Vilasar A, Ignacio QJ. Psychopathological evaluation of traumatic brain injury patients with the neuropsychiatric inventory. Rev Psiquiatr Salud Ment. 2012;5(3):160–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Fonda JR, Fredman L, Brogly SB, McGlinchey RE, Milberg WP, Gradus JL. Traumatic brain injury and attempted suicide among veterans of the wars in Iraq and Afghanistan. Am J Epidemiol. 2017;186(2):220–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Fisher LB, Pedrelli P, Iverson GL, Bergquist TF, Bombardier CH, Hammond FM, et al. Prevalence of suicidal behaviour following traumatic brain injury: longitudinal follow-up data from the NIDRR traumatic brain injury model systems. Brain Inj. 2016;30(11):1311–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Godbolt AK, Cancelliere C, Hincapie CA, Marras C, Boyle E, Kristman VL, et al. Systematic review of the risk of dementia and chronic cognitive impairment after mild traumatic brain injury: results of the international collaboration on mild traumatic brain injury prognosis. Arch Phys Med Rehabil. 2014;95(3 Suppl):S245–56.PubMedCrossRefGoogle Scholar
  24. 24.
    Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015;77(6):987–95.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Albrecht JS, Mullins DC, Smith GS, Rao V. Psychotropic medication use among medicare beneficiaries following traumatic brain injury. Am J Geriatr Psychiatry. 2017;25(4):415–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Childers MK, Holland D, Ryan MG, Rupright J. Obsessional disorders during recovery from severe head injury: report of four cases. Brain Inj. 1998;12(7):613–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Ciurli P, Formisano R, Bivona U, Cantagallo A, Angelelli P. Neuropsychiatric disorders in persons with severe traumatic brain injury: prevalence, phenomenology, and relationship with demographic, clinical, and functional features. J Head Trauma Rehabil. 2011;26(2):116–26.PubMedCrossRefGoogle Scholar
  28. 28.
    Cotrena C, Branco LD, Zimmermann N, Cardoso CO, Grassi-Oliveira R, Fonseca RP. Impaired decision-making after traumatic brain injury: the Iowa gambling task. Brain Inj. 2014;28(8):1070–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Arbour C, Gelinas C. Behavioral and physiologic indicators of pain in nonverbal patients with a traumatic brain injury: an integrative review. Pain Manag Nurs. 2014;15(2):506–18.PubMedCrossRefGoogle Scholar
  30. 30.
    Batty RA, Francis A, Thomas N, Hopwood M, Ponsford J, Rossell SL. A brief neurocognitive assessment of patients with psychosis following traumatic brain injury (PFTBI): use of the repeatable battery for the assessment of neuropsychological status (RBANS). Psychiatry Res. 2016;237:27–36.PubMedCrossRefGoogle Scholar
  31. 31.
    Diaz AP, Schwarzbold ML, Thais ME, Cavallazzi GG, Schmoeller R, Nunes JC, et al. Personality changes and return to work after severe traumatic brain injury: a prospective study. Rev Bras Psiquiatr. 2014;36(3):213–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Grima N, Ponsford J, Rajaratnam SM, Mansfield D, Pase MP. Sleep disturbances in traumatic brain injury: a meta-analysis. J Clin Sleep Med: JCSM. 2016;12(3):419–28.PubMedCrossRefGoogle Scholar
  33. 33.
    Grima NA, Ponsford JL, St Hilaire MA, Mansfield D, Rajaratnam SM. Circadian melatonin rhythm following traumatic brain injury. Neurorehabil Neural Repair. 2016;30(10):972–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Maneewong J, Maneeton B, Maneeton N, Vaniyapong T, Traisathit P, Sricharoen N, et al. Delirium after a traumatic brain injury: predictors and symptom patterns. Neuropsychiatr Dis Treat. 2017;13:459–65.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Kadyan V, Mysiw WJ, Bogner JA, Corrigan JD, Fugate LP, Clinchot DM. Gender differences in agitation after traumatic brain injury. Am J Phys Med Rehabil. 2004;83(10):747–52.PubMedCrossRefGoogle Scholar
  36. 36.
    Mahmood S, Al-Thani H, El-Menyar A, Alani M, Al-Hassani A, Mathrdikkal S, et al. Tramadol in traumatic brain injury: should we continue to use it? J Anaesthesiol Clin Pharmacol. 2015;31(3):344–8.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Bombardier CH, Hoekstra T, Dikmen S, Fann JR. Depression trajectories during the first year after traumatic brain injury. J Neurotrauma. 2016;33(23):2115–24.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Bay E, Donders J. Risk factors for depressive symptoms after mild-to-moderate traumatic brain injury. Brain Inj. 2008;22(3):233–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Dunlop TW, Udvarhelyi GB, Stedem AF, O'Connor JM, Isaacs ML, Puig JG, et al. Comparison of patients with and without emotional/behavioral deterioration during the first year after traumatic brain injury. J Neuropsychiatry Clin Neurosci. 1991;3(2):150–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Chi YC, Wu HL, Chu CP, Huang MC, Lee PC, Chen YY. Traumatic brain injury and affective disorder: a nationwide cohort study in Taiwan, 2000-2010. J Affect Disord. 2016;191:56–61.PubMedCrossRefGoogle Scholar
  41. 41.
    Albrecht JS, Kiptanui Z, Tsang Y, Khokhar B, Smith GS, Zuckerman IH, et al. Patterns of depression treatment in medicare beneficiaries with depression after traumatic brain injury. J Neurotrauma. 2015;32(16):1223–9.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Bryson CN, Cramer RJ, Schmidt AT. Traumatic brain injury and lifetime suicidality: applying the interpersonal-psychological theory perspective. Death Stud. 2017;41(7):399–405.PubMedCrossRefGoogle Scholar
  43. 43.
    Scofield DE, Proctor SP, Kardouni JR, Hill OT, McKinnon CJ. Risk factors for mild traumatic brain injury and subsequent post-traumatic stress disorder and mental health disorders among United States Army soldiers. J Neurotrauma. 2017;34(23):3249–55.PubMedCrossRefGoogle Scholar
  44. 44.
    Feinstein A, Hershkop S, Ouchterlony D, Jardine A, McCullagh S. Posttraumatic amnesia and recall of a traumatic event following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2002;14(1):25–30.PubMedCrossRefGoogle Scholar
  45. 45.
    Mellman TA, David D, Bustamante V, Fins AI, Esposito K. Predictors of post-traumatic stress disorder following severe injury. Depress Anxiety. 2001;14(4):226–31.PubMedCrossRefGoogle Scholar
  46. 46.
    Bailie JM, Kennedy JE, French LM, Marshall K, Prokhorenko O, Asmussen S, et al. Profile analysis of the neurobehavioral and psychiatric symptoms following combat-related mild traumatic brain injury: identification of subtypes. J Head Trauma Rehabil. 2016;31(1):2–12.PubMedCrossRefGoogle Scholar
  47. 47.
    Albicini MS, Lee J, McKinlay A. Ongoing daytime behavioural problems in university students following childhood mild traumatic brain injury. Int J Rehabil Res. 2016;39(1):77–83.PubMedCrossRefGoogle Scholar
  48. 48.
    James ML, Olson DM, Graffagnino C. A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth Intensive Care. 2012;40(6):949–57.PubMedGoogle Scholar
  49. 49.
    Levy M, Berson A, Cook T, Bollegala N, Seto E, Tursanski S, et al. Treatment of agitation following traumatic brain injury: a review of the literature. NeuroRehabilitation. 2005;20(4):279–306.PubMedGoogle Scholar
  50. 50.
    Luaute J, Plantier D, Wiart L, Tell L. Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations. Ann Phys Rehabil Med. 2016;59(1):58–67.PubMedCrossRefGoogle Scholar
  51. 51.
    Krieger D, Hansen K, McDermott C, Matthews R, Mitchell R, Bollegala N, et al. Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury. NeuroRehabilitation. 2003;18(3):205–8.PubMedGoogle Scholar
  52. 52.
    Noe E, Ferri J, Trenor C, Chirivella J. Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. Behav Neurol. 2007;18(1):7–11.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Kim E, Bijlani M. A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006;18(4):547–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Phelps TI, Bondi CO, Mattiola VV, Kline AE. Relative to typical antipsychotic drugs, Aripiprazole is a safer alternative for alleviating behavioral disturbances after experimental brain trauma. Neurorehabil Neural Repair. 2017;31(1):25–33.PubMedCrossRefGoogle Scholar
  55. 55.
    Folweiler KA, Bondi CO, Ogunsanya EA, LaPorte MJ, Leary JB, Radabaugh HL, et al. Combining the antipsychotic drug haloperidol and environmental enrichment after traumatic brain injury is a double-edged sword. J Neurotrauma. 2017;34(2):451–8.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Hoffman AN, Cheng JP, Zafonte RD, Kline AE. Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci. 2008;83(17–18):602–7.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Kline AE, Hoffman AN, Cheng JP, Zafonte RD, Massucci JL. Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury. Neurosci Lett. 2008;448(3):263–7.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17(4):300–13.PubMedCrossRefGoogle Scholar
  59. 59.
    Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury--a state-of-the-art review. J Rehabil Res Dev. 2009;46(6):851–79.PubMedCrossRefGoogle Scholar
  60. 60.
    Leone H, Polsonetti BW. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation? J Clin Pharm Ther. 2005;30(2):101–4.PubMedCrossRefGoogle Scholar
  61. 61.
    Gramish JA, Kopp BJ, Patanwala AE. Effect of amantadine on agitation in critically ill patients with traumatic brain injury. Clin Neuropharmacol. 2017;40(5):212–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Grima NA, Rajaratnam SMW, Mansfield D, Sletten TL, Spitz G, Ponsford JL. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Med. 2018;16(1):8.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Cantor JB, Ashman T, Bushnik T, Cai X, Farrell-Carnahan L, Gumber S, et al. Systematic review of interventions for fatigue after traumatic brain injury: a NIDRR traumatic brain injury model systems study. J Head Trauma Rehabil. 2014;29(6):490–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Leeds PR, Yu F, Wang Z, Chiu CT, Zhang Y, Leng Y, et al. A new avenue for lithium: intervention in traumatic brain injury. ACS Chem Neurosci. 2014;5(6):422–33.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Jorge RE, Acion L, Burin DI, Robinson RG. Sertraline for preventing mood disorders following traumatic brain injury: a randomized clinical trial. JAMA Psychiat. 2016;73(10):1041–7.CrossRefGoogle Scholar
  66. 66.
    Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics. 2001;42(1):48–54.PubMedCrossRefGoogle Scholar
  67. 67.
    Failla MD, Juengst SB, Graham KM, Arenth PM, Wagner AK. Effects of depression and antidepressant use on cognitive deficits and functional cognition following severe traumatic brain injury. J Head Trauma Rehabil. 2016;31(6):E62–73.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Horsfield SA, Rosse RB, Tomasino V, Schwartz BL, Mastropaolo J, Deutsch SI. Fluoxetine’s effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med. 2002;32(4):337–44.PubMedCrossRefGoogle Scholar
  69. 69.
    Khokhar B, Simoni-Wastila L, Albrecht JS. Risk of stroke among older medicare antidepressant users with traumatic brain injury. J Head Trauma Rehabil. 2017;32(1):E42–E9.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Lanctot KL, Rapoport MJ, Chan F, Rajaram RD, Strauss J, Sicard T, et al. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Inj. 2010;24(7–8):959–69.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Adamson BC, Ensari I, Motl RW. Effect of exercise on depressive symptoms in adults with neurologic disorders: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1329–38.PubMedCrossRefGoogle Scholar
  72. 72.
    Bogdanova Y, Yee MK, Ho VT, Cicerone KD. Computerized cognitive rehabilitation of attention and executive function in acquired brain injury: a systematic review. J Head Trauma Rehabil. 2016;31(6):419–33.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Bedard M, Felteau M, Marshall S, Dubois S, Gibbons C, Klein R, et al. Mindfulness-based cognitive therapy: benefits in reducing depression following a traumatic brain injury. Adv Mind Body Med. 2012;26(1):14–20.PubMedGoogle Scholar
  74. 74.
    Gertler P, Tate RL, Cameron ID. Non-pharmacological interventions for depression in adults and children with traumatic brain injury. Cochrane Database Syst Rev. 2015;12:CD009871.Google Scholar
  75. 75.
    Ahmed F, Bechtold K, Smith G, Roy D, Everett A, Rao V. Program of enhanced psychiatric services for patients with brain injury and neuropsychiatric disturbances: a proposed model of care. J Neuropsychiatry Clin Neurosci. 2016;28(2):147–52.PubMedCrossRefGoogle Scholar
  76. 76.
    Zack MM, Kobau R. National and state estimates of the numbers of adults and children with active epilepsy - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(31):821–5.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Del Felice A, Beghi E, Boero G, La Neve A, Bogliun G, De Palo A, et al. Early versus late remission in a cohort of patients with newly diagnosed epilepsy. Epilepsia. 2010;51(1):37–42.PubMedCrossRefGoogle Scholar
  79. 79.
    Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069–77.PubMedCrossRefGoogle Scholar
  80. 80.
    Hamid H, Blackmon K, Cong X, Dziura J, Atlas LY, Vickrey BG, et al. Mood, anxiety, and incomplete seizure control affect quality of life after epilepsy surgery. Neurology. 2014;82(10):887–94.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    National Association of Epilepsy Centers. Data of Participating Epilepsy Centers. http://www.naec 2012. Accessed 24 Apr.
  82. 82.
    Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922–30.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    West S, Nolan SJ, Cotton J, Gandhi S, Weston J, Sudan A, et al. Surgery for epilepsy. Cochrane Database Syst Rev. 2015;(7):Cd010541.Google Scholar
  84. 84.
    Schmidt D, Baumgartner C, Loscher W. The chance of cure following surgery for drug-resistant temporal lobe epilepsy. What do we know and do we need to revise our expectations? Epilepsy Res. 2004;60(2–3):187–201.PubMedGoogle Scholar
  85. 85.
    de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet (London, England). 2011;378(9800):1388–95.CrossRefGoogle Scholar
  86. 86.
    Engel J Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg lecture. Neurology. 2016;87(23):2483–9.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Berg AT, Langfitt J, Shinnar S, Vickrey BG, Sperling MR, Walczak T, et al. How long does it take for partial epilepsy to become intractable? Neurology. 2003;60(2):186–90.PubMedCrossRefGoogle Scholar
  88. 88.
    Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015;313(3):285–93.PubMedCrossRefGoogle Scholar
  89. 89.
    Kaiboriboon K, Malkhachroum AM, Zrik A, Daif A, Schiltz NM, Labiner DM, et al. Epilepsy surgery in the United States: analysis of data from the National Association of epilepsy centers. Epilepsy Res. 2015;116:105–9.PubMedCrossRefGoogle Scholar
  90. 90.
    Sawant N, Ravat S, Muzumdar D, Shah U. Is psychiatric assessment essential for better epilepsy surgery outcomes? Int J Surg (London, England). 2016;36(Pt B):460–5.CrossRefGoogle Scholar
  91. 91.
    Cossu M, Fuschillo D, Cardinale F, Castana L, Francione S, Nobili L, et al. Stereo-EEG-guided radio-frequency thermocoagulations of epileptogenic grey-matter nodular heterotopy. J Neurol Neurosurg Psychiatry. 2014;85(6):611–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Dimova P, de Palma L, Job-Chapron AS, Minotti L, Hoffmann D, Kahane P. Radiofrequency thermocoagulation of the seizure-onset zone during stereoelectroencephalography. Epilepsia. 2017;58(3):381–92.PubMedCrossRefGoogle Scholar
  93. 93.
    Wicks RT, Jermakowicz WJ, Jagid JR, Couture DE, Willie JT, Laxton AW, et al. Laser interstitial thermal therapy for mesial temporal lobe epilepsy. Neurosurgery. 2016;79(Suppl 1):S83–s91.PubMedCrossRefGoogle Scholar
  94. 94.
    Jermakowicz WJ, Kanner AM, Sur S, Bermudez C, D'Haese PF, Kolcun JPG, et al. Laser thermal ablation for mesiotemporal epilepsy: analysis of ablation volumes and trajectories. Epilepsia. 2017;58(5):801–10.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Chan AY, Rolston JD, Rao VR, Chang EF. Effect of neurostimulation on cognition and mood in refractory epilepsy. Epilepsia Open. 2018;3(1):18–29.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Hauser WA. The natural history of drug resistant epilepsy: epidemiologic considerations. Epilepsy Res Suppl. 1992;5:25–8.PubMedGoogle Scholar
  97. 97.
    Engel J Jr. Surgery for seizures. N Engl J Med. 1996;334(10):647–52.PubMedCrossRefGoogle Scholar
  98. 98.
    Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia. 2003;44(6):741–51.PubMedCrossRefGoogle Scholar
  99. 99.
    Holmes GL, Dorothee Kasteleijn-Nolst Trenite GA, Schachter SC. Behavioral aspects of epilepsy principles and practice. New York: Demos Medical Publishing; 2007.Google Scholar
  100. 100.
    Pre-surgical evaluation for epilepsy surgery - European standards. European federation of neurological societies task force. Eur J Neurol. 2000;7(1):119–22.CrossRefGoogle Scholar
  101. 101.
    Dodrill BPH B, Rausch R, Chelune G, Oxbury S. Surgical treatment of epilepsies. In: Engel Jr J, editor. Use of neuropsychological tests for assessing prognosis following surgery for epilepsy. 2nd ed. New York: Raven Press; 1993. p. 263e271.Google Scholar
  102. 102.
    Jones-Gotman M. Localization of lesions by neuropsychological testing. Epilepsia. 1991;32(Suppl 5):S41–52.PubMedGoogle Scholar
  103. 103.
    Baxendale S, Thompson P, Harkness W, Duncan J. Predicting memory decline following epilepsy surgery: a multivariate approach. Epilepsia. 2006;47(11):1887–94.PubMedCrossRefGoogle Scholar
  104. 104.
    Alpherts WC, Vermeulen J, van Rijen PC, da Silva FH, van Veelen CW. Verbal memory decline after temporal epilepsy surgery?: a 6-year multiple assessments follow-up study. Neurology. 2006;67(4):626–31.PubMedCrossRefGoogle Scholar
  105. 105.
    Pintor L, Bailles E, Fernandez-Egea E, Sanchez-Gistau V, Torres X, Carreno M, et al. Psychiatric disorders in temporal lobe epilepsy patients over the first year after surgical treatment. Seizure. 2007;16(3):218–25.PubMedCrossRefGoogle Scholar
  106. 106.
    Tellez-Zenteno JF, Wiebe S. Chapter 1 – Prevalence of psychiatric disorders in patients with epilepsy: what we think we know and what we know. In: Kanner AM, Schachter SC, editors. Psychiatric controversies in epilepsy. San Diego: Academic Press; 2008. p. 1–18.Google Scholar
  107. 107.
    Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110(4):207–20.PubMedCrossRefGoogle Scholar
  108. 108.
    Devinsky O. Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment. Epilepsy Behav: E&B. 2003;4(Suppl 4):S2–10.CrossRefGoogle Scholar
  109. 109.
    Filho GM, Rosa VP, Lin K, Caboclo LO, Sakamoto AC, Yacubian EM. Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav: E&B. 2008;13(1):196–201.CrossRefGoogle Scholar
  110. 110.
    Filho GM, Mazetto L, da Silva JM, Caboclo LO, Yacubian EM. Psychiatric comorbidity in patients with two prototypes of focal versus generalized epilepsy syndromes. Seizure. 2011;20(5):383–6.PubMedCrossRefGoogle Scholar
  111. 111.
    Manchanda R. Psychiatric disorders in epilepsy: clinical aspects. Epilepsy Behav. 2002;3(1):39–45.CrossRefGoogle Scholar
  112. 112.
    Swinkels WA, van Emde BW, Kuyk J, van Dyck R, Spinhoven P. Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE. Epilepsia. 2006;47(12):2092–103.PubMedCrossRefGoogle Scholar
  113. 113.
    Anhoury S, Brown RJ, Krishnamoorthy ES, Trimble MR. Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia. 2000;41(12):1608–15.PubMedCrossRefGoogle Scholar
  114. 114.
    Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54(3):388–98.PubMedCrossRefGoogle Scholar
  115. 115.
    Kanner AM. Chapter 16 – Should a psychiatric evaluation be included in every pre-surgical work-up? In: Kanner AM, Schachter SC, editors. Psychiatric controversies in epilepsy. San Diego: Academic Press; 2008. p. 239–54.CrossRefGoogle Scholar
  116. 116.
    Koch-Stoecker SC, Bien CG, Schulz R, May TW. Psychiatric lifetime diagnoses are associated with a reduced chance of seizure freedom after temporal lobe surgery. Epilepsia. 2017;58(6):983–93.PubMedCrossRefGoogle Scholar
  117. 117.
    Altalib HH, Berg AT, Cong X, Vickrey BG, Sperling MR, Shinnar S, et al. Presurgical depression and anxiety are not associated with worse epilepsy surgery outcome five years postoperatively. Epilepsy Behav: E&B. 2018;83:7–12.CrossRefGoogle Scholar
  118. 118.
    Koch-Stoecker S. Personality disorders as predictors of severe postsurgical psychiatric complications in epilepsy patients undergoing temporal lobe resections. Epilepsy Behav: E&B. 2002;3(6):526–31.CrossRefGoogle Scholar
  119. 119.
    Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72(9):793–9.PubMedCrossRefGoogle Scholar
  120. 120.
    Koch-Stoecker S, Schmitz B, Kanner AM. Treatment of postsurgical psychiatric complications. Epilepsia. 2013;54(Suppl 1):46–52.PubMedCrossRefGoogle Scholar
  121. 121.
    Greenberg DB. Epilepsy. In: Fogel BS, Greenberg DB, editors. Psychiatric Care of the Medical Patient. 3rd ed. New York: Oxford University Press; 2015.Google Scholar
  122. 122.
    Engel J Jr. The current place of epilepsy surgery. Curr Opin Neurol. 2018;31(2):192–7.PubMedGoogle Scholar
  123. 123.
    Cleary RA, Baxendale SA, Thompson PJ, Foong J. Predicting and preventing psychopathology following temporal lobe epilepsy surgery. Epilepsy Behav: E&B. 2013;26(3):322–34.CrossRefGoogle Scholar
  124. 124.
    Macrodimitris S, Sherman EM, Forde S, Tellez-Zenteno JF, Metcalfe A, Hernandez-Ronquillo L, et al. Psychiatric outcomes of epilepsy surgery: a systematic review. Epilepsia. 2011;52(5):880–90.PubMedCrossRefGoogle Scholar
  125. 125.
    Busch RM, Dulay MF, Kim KH, Chapin JS, Jehi L, Kalman CC, et al. Pre-surgical mood predicts memory decline after anterior temporal lobe resection for epilepsy. Arch Clin Neuropsychol. 2011;26(8):739–45.PubMedCrossRefGoogle Scholar
  126. 126.
    Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology. 2002;58(8 Suppl 5):S27–39.PubMedCrossRefGoogle Scholar
  127. 127.
    Hamid H, Liu H, Cong X, Devinsky O, Berg AT, Vickrey BG, et al. Long-term association between seizure outcome and depression after resective epilepsy surgery. Neurology. 2011;77(22):1972–6.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Reutens DC, Savard G, Andermann F, Dubeau F, Olivier A. Results of surgical treatment in temporal lobe epilepsy with chronic psychosis. Brain. 1997;120(Pt 11):1929–36.PubMedCrossRefGoogle Scholar
  129. 129.
    Devinsky O, Barr WB, Vickrey BG, Berg AT, Bazil CW, Pacia SV, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005;65(11):1744–9.PubMedCrossRefGoogle Scholar
  130. 130.
    Hermann BP, Wyler AR. Depression, locus of control, and the effects of epilepsy surgery. Epilepsia. 1989;30(3):332–8.PubMedCrossRefGoogle Scholar
  131. 131.
    Reuber M, Andersen B, Elger CE, Helmstaedter C. Depression and anxiety before and after temporal lobe epilepsy surgery. Seizure. 2004;13(2):129–35.PubMedCrossRefGoogle Scholar
  132. 132.
    Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav: E&B. 2008;13(Suppl 1):S1–29.CrossRefGoogle Scholar
  133. 133.
    Hovorka J, Herman E, Nemcova II. Treatment of Interictal depression with citalopram in patients with epilepsy. Epilepsy Behav: E&B. 2000;1(6):444–7.CrossRefGoogle Scholar
  134. 134.
    Kuhn KU, Quednow BB, Thiel M, Falkai P, Maier W, Elger CE. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav: E&B. 2003;4(6):674–9.CrossRefGoogle Scholar
  135. 135.
    Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27(3):133–6.PubMedCrossRefGoogle Scholar
  136. 136.
    Ribot R, Ouyang B, Kanner AM. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating? Epilepsy Behav: E&B. 2017;70(Pt A):5–9.CrossRefGoogle Scholar
  137. 137.
    Maguire MJ, Weston J, Singh J, Marson AG. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2014;(12):Cd010682.Google Scholar
  138. 138.
    Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia. 2011;52(11):2133–8.PubMedCrossRefGoogle Scholar
  139. 139.
    Swinkels JA, de Jonghe F. Safety of antidepressants. Int Clin Psychopharmacol. 1995;9(Suppl 4):19–25.PubMedCrossRefGoogle Scholar
  140. 140.
    Munchau A, Langosch JM, Gerschlager W, Rothwell JC, Orth M, Trimble MR. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry. 2005;76(4):527–33.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Kaufman KR, Saucedo C, Schaeffer J, Levesque M, Scannell T, Glouberman M. Electroconvulsive therapy (ECT) for intractable depression following epilepsy neurosurgery. Seizure. 1996;5(4):307–12.PubMedCrossRefGoogle Scholar
  142. 142.
    Aksoy-Poyraz C, Ozdemir A, Ozmen M, Arikan K, Ozkara C. Electroconvulsive therapy for bipolar depressive and mixed episode with high suicide risk after epilepsy surgery. Epilepsy Behav: E&B. 2008;13(4):707–9.CrossRefGoogle Scholar
  143. 143.
    Beyenburg S, Mitchell AJ, Schmidt D, Elger CE, Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav: E&B. 2005;7(2):161–71.CrossRefGoogle Scholar
  144. 144.
    Manchanda R, Schaefer B, McLachlan RS, Blume WT, Wiebe S, Girvin JP, et al. Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry. 1996;61(1):82–9.PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Ring HA, Moriarty J, Trimble MR. A prospective study of the early postsurgical psychiatric associations of epilepsy surgery. J Neurol Neurosurg Psychiatry. 1998;64(5):601–4.PubMedPubMedCentralCrossRefGoogle Scholar
  146. 146.
    Wrench J, Wilson SJ, Bladin PF. Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections. Epilepsia. 2004;45(5):534–43.PubMedCrossRefGoogle Scholar
  147. 147.
    Mula M, Monaco F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord. 2009;11(1):1–9.PubMedGoogle Scholar
  148. 148.
    Harnod T, Wang YC, Kao CH. Association between benzodiazepine use and epilepsy occurrence: a Nationwide population-based case-control study. Medicine (Baltimore). 2015;94(37):e1571.CrossRefGoogle Scholar
  149. 149.
    Monaco F, Cavanna A, Magli E, Barbagli D, Collimedaglia L, Cantello R, et al. Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy. Epilepsy Behav: E&B. 2005;7(3):491–6.CrossRefGoogle Scholar
  150. 150.
    Kulaksizoglu IB, Bebek N, Baykan B, Imer M, Gurses C, Sencer S, et al. Obsessive-compulsive disorder after epilepsy surgery. Epilepsy Behav: E&B. 2004;5(1):113–8.CrossRefGoogle Scholar
  151. 151.
    Roth RM, Jobst BC, Thadani VM, Gilbert KL, Roberts DW. New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder. Epilepsy Behav: E&B. 2009;14(4):677–80.CrossRefGoogle Scholar
  152. 152.
    Schmitz B. Depression and mania in patients with epilepsy. Epilepsia. 2005;46(Suppl 4):45–9.PubMedCrossRefGoogle Scholar
  153. 153.
    Kanemoto K, Kawasaki J, Kawai I. Postictal psychosis: a comparison with acute interictal and chronic psychoses. Epilepsia. 1996;37(6):551–6.PubMedCrossRefGoogle Scholar
  154. 154.
    Carran MA, Kohler CG, O'Connor MJ, Bilker WB, Sperling MR. Mania following temporal lobectomy. Neurology. 2003;61(6):770–4.PubMedCrossRefGoogle Scholar
  155. 155.
    Engel J, Pedley TA, Aicardi J, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers. p. 2169–78.Google Scholar
  156. 156.
    Blumer D, Wakhlu S, Davies K, Hermann B. Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia. 1998;39(5):478–86.PubMedCrossRefGoogle Scholar
  157. 157.
    Maixner D, Sagher O, Bess J, Edwards J. Catatonia following surgery for temporal lobe epilepsy successfully treated with electroconvulsive therapy. Epilepsy Behav: E&B. 2010;19(3):528–32.CrossRefGoogle Scholar
  158. 158.
    Iranzo-Tatay C, Rubio-Granero T, Gutierrez A, Garces M, Conde R, Gomez-Ibanez A, et al. Psychiatric symptoms after temporal epilepsy surgery. A one-year follow-up study. Epilepsy Behav: E&B. 2017;70(Pt A):154–60.CrossRefGoogle Scholar
  159. 159.
    D'Alessio L, Scevola L, Fernandez Lima M, Oddo S, Solis P, Seoane E, et al. Psychiatric outcome of epilepsy surgery in patients with psychosis and temporal lobe drug-resistant epilepsy: a prospective case series. Epilepsy Behav: E&B. 2014;37:165–70.CrossRefGoogle Scholar
  160. 160.
    Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int Clin Psychopharmacol. 1995;9(Suppl 5):21–7.PubMedCrossRefGoogle Scholar
  161. 161.
    McConnell H, Duncan D. Chapter 10. Treatment of psychiatric, comorbidity in epilepsy. In: McConnell H, Snyder P, editors. Psychiatric comorbidity in epilepsy. Washington, DC: Press. DAP; 1998. p. 245–361.Google Scholar
  162. 162.
    Toth P, Frankenburg FR. Clozapine and seizures: a review. Can J Psychiatr Rev Can Psychiatr. 1994;39(4):236–8.CrossRefGoogle Scholar
  163. 163.
    Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345–54.PubMedCrossRefGoogle Scholar
  164. 164.
    Pompili M, Girardi P, Tatarelli G, Angeletti G, Tatarelli R. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep. 2006;98(2):323–38.PubMedCrossRefGoogle Scholar
  165. 165.
    Hamid H, Devinsky O, Vickrey BG, Berg AT, Bazil CW, Langfitt JT, et al. Suicide outcomes after resective epilepsy surgery. Epilepsy Behav: E&B. 2011;20(3):462–4.CrossRefGoogle Scholar
  166. 166.
    Wilson SJ, Bladin PF, Saling MM. The burden of normality: a framework for rehabilitation after epilepsy surgery. Epilepsia. 2007;48(Suppl 9):13–6.PubMedCrossRefGoogle Scholar
  167. 167.
    Ramos-Perdigues S, Bailles E, Mane A, Carreno M, Donaire A, Rumia J, et al. A prospective study contrasting the psychiatric outcome in drug-resistant epilepsy between patients who underwent surgery and a control group. Epilepsia. 2016;57(10):1680–90.PubMedCrossRefGoogle Scholar
  168. 168.
    Helmstaedter C. Cognitive outcomes of different surgical approaches in temporal lobe epilepsy. Epileptic Disord. 2013;15(3):221–39.PubMedGoogle Scholar
  169. 169.
    Vermeulen L, van Loon J, Theys T, Goffin J, Porke K, Van Laere K, et al. Outcome after epilepsy surgery at the university hospitals Leuven 1998-2012. Acta Neurol Belg. 2016;116(3):271–8.PubMedCrossRefGoogle Scholar
  170. 170.
    Lutz MT, Clusmann H, Elger CE, Schramm J, Helmstaedter C. Neuropsychological outcome after selective amygdalohippocampectomy with transsylvian versus transcortical approach: a randomized prospective clinical trial of surgery for temporal lobe epilepsy. Epilepsia. 2004;45(7):809–16.PubMedCrossRefGoogle Scholar
  171. 171.
    Ives-Deliperi VL, Butler JT. Naming outcomes of anterior temporal lobectomy in epilepsy patients: a systematic review of the literature. Epilepsy Behav: E&B. 2012;24(2):194–8.CrossRefGoogle Scholar
  172. 172.
    Lee TM, Yip JT, Jones-Gotman M. Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia. 2002;43(3):283–91.PubMedCrossRefGoogle Scholar
  173. 173.
    Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain. 2007;130(Pt 2):334–45.PubMedCrossRefGoogle Scholar
  174. 174.
    Sherman EM, Wiebe S, Fay-McClymont TB, Tellez-Zenteno J, Metcalfe A, Hernandez-Ronquillo L, et al. Neuropsychological outcomes after epilepsy surgery: systematic review and pooled estimates. Epilepsia. 2011;52(5):857–69.PubMedCrossRefGoogle Scholar
  175. 175.
    Vaz SA. Nonverbal memory functioning following right anterior temporal lobectomy: a meta-analytic review. Seizure. 2004;13(7):446–52.PubMedCrossRefGoogle Scholar
  176. 176.
    Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger CE. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. 2003;54(4):425–32.PubMedCrossRefGoogle Scholar
  177. 177.
    Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311–8.PubMedCrossRefGoogle Scholar
  178. 178.
    Elsharkawy AE, May T, Thorbecke R, Koch-Stoecker S, Villagran A, Urak L, et al. Long-term outcome and determinants of quality of life after temporal lobe epilepsy surgery in adults. Epilepsy Res. 2009;86(2–3):191–9.PubMedCrossRefGoogle Scholar
  179. 179.
    Wilson SJ, Wrench JM, McIntosh AM, Bladin PF, Berkovic SF. Profiles of psychosocial outcome after epilepsy surgery: the role of personality. Epilepsia. 2010;51(7):1133–8.PubMedCrossRefGoogle Scholar
  180. 180.
    Hamiwka L, Macrodimitris S, Tellez-Zenteno JF, Metcalfe A, Wiebe S, Kwon CS, et al. Social outcomes after temporal or extratemporal epilepsy surgery: a systematic review. Epilepsia. 2011;52(5):870–9.PubMedCrossRefGoogle Scholar
  181. 181.
    Hermann BP, Trenerry MR, Colligan RC. Learned helplessness, attributional style, and depression in epilepsy. Bozeman epilepsy surgery consortium. Epilepsia. 1996;37(7):680–6.PubMedCrossRefGoogle Scholar
  182. 182.
    Wilson S, Bladin P, Saling M. The “burden of normality”: concepts of adjustment after surgery for seizures. J Neurol Neurosurg Psychiatry. 2001;70(5):649–56.PubMedPubMedCentralCrossRefGoogle Scholar
  183. 183.
    Naesstrom M, Blomstedt P, Bodlund O. A systematic review of psychiatric indications for deep brain stimulation, with focus on major depressive and obsessive-compulsive disorder. Nord J Psychiatry. 2016;70(7):483–91.PubMedCrossRefGoogle Scholar
  184. 184.
    Youngerman BE, Chan AK, Mikell CB, McKhann GM, Sheth SA. A decade of emerging indications: deep brain stimulation in the United States. J Neurosurg. 2016;125(2):461–71.PubMedCrossRefGoogle Scholar
  185. 185.
    Kisely S, Li A, Warren N, Siskind D. A systematic review and meta-analysis of deep brain stimulation for depression. Depress Anxiety. 2018;35(5):468–80.PubMedCrossRefGoogle Scholar
  186. 186.
    Johnson MD, McIntyre CC. Quantifying the neural elements activated and inhibited by globus pallidus deep brain stimulation. J Neurophysiol. 2008;100(5):2549–63.PubMedPubMedCentralCrossRefGoogle Scholar
  187. 187.
    Barrett K. Psychiatric neurosurgery in the 21st century: overview and the growth of deep brain stimulation. BJPsych Bull. 2017;41(5):281–6.PubMedPubMedCentralCrossRefGoogle Scholar
  188. 188.
    Gross RE, McDougal ME. Technological advances in the surgical treatment of movement disorders. Curr Neurol Neurosci Rep. 2013;13(8):371.PubMedPubMedCentralCrossRefGoogle Scholar
  189. 189.
    Savica R, Grossardt BR, Rocca WA, Bower JH. Parkinson disease with and without dementia: a prevalence study and future projections. Mov Disord. 2018;33(4):537–43.PubMedCrossRefGoogle Scholar
  190. 190.
    Kulick CV, Montgomery KM, Nirenberg MJ. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson’s disease psychosis. Parkinsonism Relat Disord. 2018;pii:S1353–8020(18):30153–6.Google Scholar
  191. 191.
    Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183–9. quiz 313.PubMedCrossRefGoogle Scholar
  192. 192.
    Larsen JP, Dalen I, Pedersen KF, Tysnes OB. The natural history of depressive symptoms in patients with incident Parkinson’s disease: a prospective cohort study. J Neurol. 2017;264(12):2401–8.PubMedCrossRefGoogle Scholar
  193. 193.
    Wang JW, Zhang YQ, Zhang XH, Wang YP, Li JP, Li YJ. Cognitive and psychiatric effects of STN versus GPi deep brain stimulation in Parkinson’s disease: a meta-analysis of randomized controlled trials. PLoS One. 2016;11(6):e0156721.PubMedPubMedCentralCrossRefGoogle Scholar
  194. 194.
    Broen MPG, Leentjens AFG, Hinkle JT, Moonen AJH, Kuijf ML, Fischer NM, et al. Clinical markers of anxiety subtypes in Parkinson disease. J Geriatr Psychiatry Neurol. 2018;31(2):55–62.PubMedPubMedCentralCrossRefGoogle Scholar
  195. 195.
    Merims D, Balas M, Peretz C, Shabtai H, Giladi N. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol. 2006;29(6):331–7.PubMedCrossRefGoogle Scholar
  196. 196.
    Thomas AA, Friedman JH. Current use of clozapine in Parkinson disease and related disorders. Clin Neuropharmacol. 2010;33(1):14–6.PubMedCrossRefGoogle Scholar
  197. 197.
    Majlath Z, Obal I, Vecsei L. Treatment possibilities for psychosis in Parkinson’s disease with an emphasis on the newly approved drug: Pimavanserin. CNS Neurol Disord Drug Targets. 2017;16(3):234–43.PubMedCrossRefGoogle Scholar
  198. 198.
    Andre M, Rezai AR, Kopell BH, Gross RE, Sharan AD, Benabid AL. Deep brain stimulation for Parkinson’s disease: surgical technique and perioperative management. Mov Disord. 2006;21(14):S247–S58.Google Scholar
  199. 199.
    Fidel BCJ, Richard S, Joseph J. Diagnosis and treatment of complications related to deep brain stimulation hardware. Mov Disord. 2011;26(8):1398–406.CrossRefGoogle Scholar
  200. 200.
    Günther D, Jan H, Galit KF, Cynthia K, Lozano AM, Lyons KE, et al. Deep brain stimulation: postoperative issues. Mov Disord. 2006;21(14):S219–S37.Google Scholar
  201. 201.
    Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology. 2012;14(Suppl 5):v1–v49.PubMedPubMedCentralCrossRefGoogle Scholar
  202. 202.
    Keschner M, Bender MB, Strauss I. Mental symptoms associated with brain tumor: a study of 530 verified cases. JAMA. 1938;110(10):714–8.CrossRefGoogle Scholar
  203. 203.
    Kaplan HISB. Psychiatric aspects of brain tumors: a review. Mental disorders due to general medical condition. In: Kaplan HI, Sadock BJ, editors. Synopsis of psychiatry. 8th ed. Philadelphia: Lippincot Williams & Wilkins; 1998. p. 350–64.Google Scholar
  204. 204.
    Gupta RK, Kumar R. Benign brain tumours and psychiatric morbidity: a 5-years retrospective data analysis. Aust N Z J Psychiatry. 2004;38(5):316–9.PubMedCrossRefGoogle Scholar
  205. 205.
    Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr. Depression in patients with high-grade glioma: results of the Glioma outcomes project. Neurosurgery. 2004;54(2):358–66. discussion 66-7.PubMedCrossRefGoogle Scholar
  206. 206.
    Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: a review. World J Psychiatry. 2015;5(3):273–85.PubMedPubMedCentralCrossRefGoogle Scholar
  207. 207.
    Boettger S, Jenewein J, Breitbart W. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: a comparison of efficacy, safety, and side effects. Palliat Support Care. 2015;13(4):1079–85.PubMedCrossRefGoogle Scholar
  208. 208.
    Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153(2):231–7.PubMedCrossRefGoogle Scholar
  209. 209.
    Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A, et al. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol. 2009;71(3):299–303. discussion.PubMedCrossRefGoogle Scholar
  210. 210.
    Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998;16(7):2522–7.PubMedCrossRefGoogle Scholar
  211. 211.
    Caudill JS, Brown PD, Cerhan JH, Rummans TA. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience. Am J Clin Oncol. 2011;34(4):385–7.PubMedCrossRefGoogle Scholar
  212. 212.
    Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol. 2012;107(1):165–74.CrossRefGoogle Scholar
  213. 213.
    Roth AJ, Jaeger A. Psychiatric issues in cancer patients. In: The American Cancer Society’s principles of oncology: John Wiley & Sons, Inc; 2018. p. 379–92.Google Scholar
  214. 214.
    Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2013;(5):Cd006932.Google Scholar
  215. 215.
    Robinson S, Kissane DW, Brooker J, Burney S. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manag. 2015;49(3):595–610.CrossRefGoogle Scholar
  216. 216.
    Mehta RD, Roth AJ. Psychiatric considerations in the oncology setting. CA Cancer J Clin. 2015;65(4):299–314.CrossRefGoogle Scholar
  217. 217.
    Conklin HM, Reddick WE, Ashford J, Ogg S, Howard SC, Morris EB, et al. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol. 2010;28(29):4465–72.PubMedPubMedCentralCrossRefGoogle Scholar
  218. 218.
    Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, et al. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer. 2012;59(3):540–7.PubMedPubMedCentralCrossRefGoogle Scholar
  219. 219.
    Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol. 2015;33(15):1653–9.PubMedPubMedCentralCrossRefGoogle Scholar
  220. 220.
    Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology. 2013;15(10):1429–37.PubMedPubMedCentralCrossRefGoogle Scholar
  221. 221.
    Price TRGK, Lovell MR. Neuropsychiatric aspects of brain tumors. In: Yudofsky SC, Hales RE, editors. The American Psychiatric Publishing textbook of neuropsychiatry and behavioral neurosciences. 5th ed. Arlington: American Psychiatric Publishing; 2007. p. 735–64.Google Scholar
  222. 222.
    Rossetti AO, Stupp R. Epilepsy in brain tumor patients. Curr Opin Neurol. 2010;23(6):603–9.PubMedCrossRefGoogle Scholar
  223. 223.
    Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2000;54(10):1886–93.PubMedCrossRefGoogle Scholar
  224. 224.
    Halma E, de Louw AJ, Klinkenberg S, Aldenkamp AP, DM IJ, Majoie M. Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review. Seizure. 2014;23(9):685–91.PubMedCrossRefGoogle Scholar
  225. 225.
    Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–7.PubMedCrossRefGoogle Scholar
  226. 226.
    Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord. 1983;5(4):319–32.PubMedCrossRefGoogle Scholar
  227. 227.
    Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92(5):500–5.PubMedCrossRefGoogle Scholar
  228. 228.
    Dubovsky AN, Arvikar S, Stern TA, Axelrod L. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosom. 2012;53(2):103–15.CrossRefGoogle Scholar
  229. 229.
    LA Davis JM, Merk BS, Janicak PG. Treatment of steroid psychoses. Psychiatr Ann. 1992;22:487–91.CrossRefGoogle Scholar
  230. 230.
    Hurria A, Somlo G, Ahles T. Renaming “chemobrain”. Cancer Investig. 2007;25(6):373–7.CrossRefGoogle Scholar
  231. 231.
    Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care. 2007;5(3):273–80.PubMedCrossRefGoogle Scholar
  232. 232.
    Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011;38(3):431–8.PubMedPubMedCentralCrossRefGoogle Scholar
  233. 233.
    Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65(2):123–38.PubMedCrossRefGoogle Scholar
  234. 234.
    Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, et al. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013;22(2):161–78.PubMedCrossRefGoogle Scholar
  235. 235.
    Clinical radiation oncology [electronic resource]. Bogart JA, Gunderson LL, Tepper JE, editors. Philadelphia: Elsevier; 2016.Google Scholar
  236. 236.
    Hess CB, Chen AM. Measuring psychosocial functioning in the radiation oncology clinic: a systematic review. Psychooncology. 2014;23(8):841–54.PubMedCrossRefGoogle Scholar
  237. 237.
    Holmes EG, Holmes JA, Park EM. Psychiatric care of the radiation oncology patient. Psychosomatics. 2017;58(5):457–65.PubMedPubMedCentralCrossRefGoogle Scholar
  238. 238.
    Greenberg DB. Brain tumor. In: Fogel BS, Greenberg DB, editors. Psychiatric care of the medical patient. 3rd ed. New York, USA: Oxford University Press; 2015.Google Scholar
  239. 239.
  240. 240.
    Kim S, Akpati HC, Li JG, Liu CR, Amdur RJ, Palta JR. An immobilization system for claustrophobic patients in head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2004;59(5):1531–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Yale University School of Medicine, Department of PsychiatryNew HavenUSA
  2. 2.Department of Psychiatry and Surgery (Transplant)Yale University School of Medicine, Yale UniversityNew HavenUSA

Personalised recommendations